Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Screenshot 2024 06 06 at 14 01 14

Semarion receives received the SLAS Ignite Award

Semarion was recently recognised for its innovative approach at the SLAS Awards.

Congratulations to portfolio company Semarion, who recently received the SLAS Ignite Award at SLAS (Society for Laboratory Automation and Screening) Europe last week!

The award recognises Semarion as the most innovative company in the field of laboratory automation in Europe.

Semarion's Semacyte microcarriers function as ultra-miniaturised, mobile, barcoded wells that carry small colonies of adherent cells that can be moved using liquid handling tools. Multiplexing and combining different barcoded adherent cell types in one well enables pooled cell screening, which accelerates discovery campaigns and reduces the resource burden of cell testing.

Find out more about how Semarion is revolutionising in vitro drug discovery